Melqart Asset Management (Uk) LTD Horizon Therapeutics Public LTD CO Transaction History

Melqart Asset Management (Uk) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $14.1 Million - $16.5 Million	-142,703 Reduced 11.19%	1,132,818 $131 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $8.63 Million - $10.1 Million	89,598 Added 7.56%	1,275,521 $131 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $49.3 Million - $52.2 Million	459,839 Added 63.33%	1,185,923 $129 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $45.3 Million - $82.6 Million	726,084 New	726,084 $82.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.